NCT00156533
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
See it on ClinicalTrials.gov ↗20 people
70%
30%
14 womenmiddle line = equal numbers6 men
- Phase
- PHASE4
- Paid for by
- University of Rochester
- Finished
- 2008-02
- Health conditions
- Insomnia, Primary Insomnia, Psychophysiologic Insomnia
- Who could join
- Anyone
- Ages
- 25 Years – 55 Years
- Average age
- Not reported
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 55 Years.”
- No pregnant women
Women who were pregnant could not join.
“pregnancy”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Unstable medical or psychiatric illness”
Study titles and rules are shown in their original English.